Daytime Station Support Program
Membership Campaign Program
Summer of Service Program
A Republican Congressional primary and a surprise Democratic resignation upend Virginia politics. A longtime D.C. politician gets back in the game by announcing an independent mayoral campaign. And Maryland's front-running gubernatorial candidate opens up a lead in the polls, while the state's race for attorney general tightens up down the final stretch. Join us for our weekly review of the politics, policies, and personalities of the District of Columbia, Maryland and Virginia.
Maryland Attorney General Douglas Gansler (D) said Lt. Gov Anthony Brown, a fellow Democratic gubernatorial candidate, had taken to "attack[ing] my family and me personally" as the two, along with Maryland Del. Heather Mizeur, vie for a nod in the June 24 primary.
When a caller on the Kojo Nnamdi Show's Politics Hour questioned Gansler's judgement and ability to serve the state's top office, referencing Gansler's choice not to intervene in a party that allegedly included underage drinking when he stopped by the gathering to speak to his son, Gansler defended his "22 years of public service."
It wasn't until Brown entered the race, Gansler said, that people had ever questioned his judgement or character.
He noted neither the police nor the chaperones of the party shut the gathering down when they had stopped by the Delaware beach house earlier in the evening.
"I think people can see through those kinds of tricks and dirty politics," he said.
Maryland "could not be worse in terms of transparency and open government, Attorney General Doug Gansler told Kojo Nnamdi on Friday on his weekly Politics Hour.
Watch the clip below to see Gansler discuss his plans to improve transparency across the state.
Watch the full video of our Politics Hour with Doug Gansler and WAMU reporter Matt Bush.
Earlier this month, the House of Representatives passed the 21st Century Cures Act in a rare bi-partisan effort. The bill is meant to speed the development of lifesaving treatments, but critics warn it may also allow ineffective or even harmful drugs onto the market.